SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Michael M. Hopkins · Study

Home/Author

Michael M. Hopkins

14 works· latest 2020· 1 institutionscluster: provisionalORCID 0000-0002-8401-6573

h-index13

i1014

Citations535

Works here14

02

06

07

10

12

13

15

16

19

20

Most cited in this library

Big Pharma, little science?2012 · 133 citations
Funding Data from Publication Acknowledgments: Coverage, Uses, and Limitations2016 · 75 citations
Strategic Intelligence on Emerging Technologies: Scientometric Overlay Mapping2015 · 71 citations
DNA patenting: the end of an era?2007 · 43 citations
Generative and degenerative interactions: positive and negative dynamics of open, user‐centric innovation in technology and engineering consultancies2010 · 39 citations

Works

14 shown

DARE to be different? A novel approach for analysing diversity in collaborative research projects

Research Evaluation·2020·7 authors·Open access

24citations

Continental drift? Do European clinical genetic testing laboratories have a patent problem?

European Journal of Human Genetics·2019·8 authors·Open access

15citations

Funding Data from Publication Acknowledgments: Coverage, Uses, and Limitations

Journal of the Association for Information Science and Technology·2016·5 authors·Open access

75citations

Scientometric Mapping as a Strategic Intelligence Tool for the Governance of Emerging Technologies.

SSRN Electronic Journal·2016·4 authors·preprint·Open access

18citations

Funding Data from Publication Acknowledgements: Coverage, Uses and Limitations.

SSRN Electronic Journal·2016·5 authors·preprint·Open access

14citations

Landscape Review of Interdisciplinary Research in the UK

Sussex Research Online (University of Sussex)·2016·11 authors

13citations

Strategic Intelligence on Emerging Technologies: Scientometric Overlay Mapping

Figshare·2015·4 authors·Open access

71citations

Just how difficult can it be counting up R&D funding for emerging technologies (and is tech mining with proxy measures going to be any better)?

Technology Analysis and Strategic Management·2013·2 authors·Open access

22citations

Big Pharma, little science?

Technological Forecasting and Social Change·2012·7 authors·Open access

133citations

Biomarker patents for diagnostics: problem or solution?

Nature Biotechnology·2012·2 authors·Open access

12citations

Generative and degenerative interactions: positive and negative dynamics of open, user‐centric innovation in technology and engineering consultancies

R and D Management·2010·4 authors·Open access

39citations

DNA patenting: the end of an era?

Nature Biotechnology·2007·4 authors

43citations

Strategic risk management using complementary assets: Organizational capabilities and the commercialization of human genetic testing in the UK

Research Policy·2006·2 authors·Open access

36citations

Shares in the human genome—the future of patenting DNA

Nature Biotechnology·2002·3 authors·Open access

20citations